Cardiac tolerability of concurrent administration of trastuzumab and anthracycline-based regimen as adjuvant chemotherapy for breast cancer.
about
Concurrent administration of trastuzumab and anthracyclines as adjuvant regimen for HER2-positive breast cancer: a randomised controlled trial.Evaluation of QTc Interval Prolongation in Breast Cancer Patients after Treatment with Epirubicin, Cyclophosphamide, and Docetaxel and the Influence of Interobserver Variation.
P2860
Cardiac tolerability of concurrent administration of trastuzumab and anthracycline-based regimen as adjuvant chemotherapy for breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@en
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@nl
type
label
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@en
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@nl
prefLabel
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@en
Cardiac tolerability of concur ...... hemotherapy for breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
Cardiac tolerability of concur ...... chemotherapy for breast cancer
@en
P2093
Kaori Uchino
Reiko Shimojima
Shoko Otsuka
Yoko Sasaki
P2860
P356
10.1159/000358754
P577
2014-02-01T00:00:00Z